PTI-125

Pain Therapeutics, Inc. (NASDAQ: PTIE) shares took center stage Monday, offering pleasure rather than pain to those investing in the company. The shares of the clinical-stage biopharma company gap-opened up at $4.20, adding over 12 percent from the previous session's close of $3.74....